With their triumphant advance, biosimilars are also setting in motion the usual market mechanisms. Biopharma interest groups warn against the automatic substitution of...
US drugstore chain CVS Health has launched Cordavis, a wholly owned subsidiary that will collaborate with manufacturers to commercialize and co-produce biosimilar...
26.02.2019
- The EU is adopting new rules that should make it easier for producers of generic drugs and biosimilars in member states to compete on the global market. On Feb. 20, the states...
29.11.2018
- The MENA (Middle East and North Africa) region is a largely untapped, yet potentially hugely fruitful part of the world for the pharmaceutical industry, both as a sales region and...
19.09.2018
- The biopharmaceutical industry has grown impressively in recent years, with its global compound growth rate (CAGR) estimated to reach 8.5% between 2018-2023, outstripping...
19.09.2018
- Despite the favorable economic environment, the global economic risk factors have intensified against the background of record global debt and a rise in geopolitical risk. Amid...
